59 results
Page 2 of 3
8-K
EX-99.1
2li 1w3d4ba
5 May 22
Axcella Reports First Quarter Financial Results and Provides Business Update
7:41am
8-K
EX-99.1
oqop1w82nh
30 Mar 22
Axcella Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:05am
424B5
x2wm636fgmo8hv
16 Mar 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
d7iy tvg0m
7 Feb 22
Axcella Therapeutics Announces Appointment of New Chief Financial Officer
4:00pm
8-K
EX-99.1
rony4e 71stw2
10 Jan 22
Other Events
8:00am
8-K
EX-99.1
tdbig4g
7 Dec 21
Departure of Directors or Certain Officers
6:15am
8-K
EX-99.1
y3foqotgj0 5n
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
8-K
EX-99.1
ldm44o6 az
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
EX-99.1
b95pde7
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.2
t03rjugvsxm4fs1iclr
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
7ui vlq5ef2
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
EX-99.1
e7m8 ky2pu6srkx4dgb
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-99.1
7awp4gxg6jquet3
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am